- Home
- SAFT vs BIOA Comparison
SAFT vs BIOA Comparison
Compare SAFT & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SAFT | BIOA |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | 62 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 967.7M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | SAFT | BIOA |
|---|---|---|
| Price | $103.51 | $10.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $51.50 |
| AVG Volume (30 Days) | 332.3K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | ★ 40.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,263,732,000.00 | N/A |
| Revenue This Year | N/A | $720.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $67.04 | $4.26 |
| 52 Week High | $103.63 | $25.96 |
Technical Indicators
Market Signals| Indicator | SAFT | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. The company operates in the business segment of Property and casualty insurance operations.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.